Safety and tolerance of dose-dense Epirubicin and Cyclophosphamide (EC) with Pegfilgrastim for Japanese patients with early breast cancer

被引:0
|
作者
Watanabe, K. [1 ]
Yamamoto, M. [1 ]
Sato, M. [1 ]
Tomioka, N. [1 ]
Takahashi, M. [1 ]
机构
[1] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
来源
BREAST | 2017年 / 32卷
关键词
D O I
10.1016/S0960-9776(17)30118-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P017
引用
收藏
页码:S27 / S28
页数:2
相关论文
共 50 条
  • [41] Feasibility study of dose dense epirubicin and cyclophosphamide in the primaly breast cancer treatment
    Morita, Sachi
    Inaishi, Takahiro
    Ota, Akiko
    Matsuoka, Ayumu
    Mizutani, Takehumi
    Shimokata, Tomoya
    Maeda, Osamu
    Mitsuma, Ayako
    Tsunoda, Nobuyuki
    Kikumori, Toyone
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Use of Dose-dense EC Chemotherapy in Early Breast Cancer - Experience from Two London Hospitals
    Amir, T.
    Chopra, N.
    Sheri, A.
    Newby, J.
    King, J.
    CLINICAL ONCOLOGY, 2022, 34 (04) : E176 - E177
  • [43] Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer
    Burdette-Radoux, Susan
    Wood, Marie E.
    Olin, Julie J.
    Laughlin, Rebecca S.
    Crocker, Abigail M.
    Ashikaga, Takamaru
    Muss, Hyman B.
    BREAST JOURNAL, 2007, 13 (03): : 274 - 280
  • [44] A dose-dense schedule of epirubicin (EPI) and vinorelbine in locally advanced breast cancer (BC).
    Nisticò, C
    de Matteis, A
    Carnino, F
    Valenza, R
    Quattrocchio, D
    Farris, A
    Rossi, E
    Agostara, B
    Vaccaro, A
    D'Ottavio, AM
    Garufi, C
    Zappalà, A
    Cappellini, GCA
    D'Attino, RM
    Terzoli, E
    ANNALS OF ONCOLOGY, 2000, 11 : 46 - 46
  • [45] Neoadjuvant dose-dense sequential biweekly epirubicin and cyclophosphamide followed by docetaxel and trastuzumab for HER2+operable breast cancer
    Blakely, L.
    Somer, B.
    Keaton, M.
    Hermann, R.
    Schnell, F.
    Cobb, P.
    Johns, A.
    Walker, M.
    Schwartzberg, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
    Mariangela Manzoni
    Sara Delfanti
    Bianca Rovati
    Donatella Grasso
    Sara Mariucci
    Katia Bencardino
    Carmine Tinelli
    Marco Danova
    Clinical and Experimental Medicine, 2010, 10 : 135 - 138
  • [47] Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
    Manzoni, Mariangela
    Delfanti, Sara
    Rovati, Bianca
    Grasso, Donatella
    Mariucci, Sara
    Bencardino, Katia
    Tinelli, Carmine
    Danova, Marco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (02) : 135 - 138
  • [48] Long-Term Cardiac Safety and Outcomes of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel and Trastuzumab With and Without Lapatinib in Patients With Early Breast Cancer
    Morris, Patrick G.
    Iyengar, Neil M.
    Patil, Sujata
    Chen, Carol
    Abbruzzi, Alyson
    Lehman, Robert
    Steingart, Richard
    Oeffinger, Kevin C.
    Lin, Nancy
    Moy, Beverley
    Come, Steven E.
    Winer, Eric P.
    Norton, Larry
    Hudis, Clifford A.
    Dang, Chau T.
    CANCER, 2013, 119 (22) : 3943 - 3951
  • [49] A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
    Kim, Gun Min
    Kim, Joo Hoon
    Kim, Ji Heung
    Cho, Young Up
    Kim, Seung Il
    Park, Seho
    Park, Hyung Seok
    Kim, Ji Ye
    Sohn, Joohyuk
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 812 - 818
  • [50] Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer
    Singh, Ashish
    Georgy, Josh Thomas
    Joel, Anjana
    Thumaty, Divya Bala
    John, Ajoy Oommen
    Ramnath, Nithya
    George, Tarun K.
    Sharma, Parth
    Patole, Shalom
    Rebekah, Grace
    Sigamani, Elanthenral
    Manipadam, Marie Therese
    Cherian, Anish Jacob
    Abraham, Deepak Thomas
    Paul, Mazhuvanchary Jacob
    Balakrishnan, Rajesh
    Sebastian, Patricia
    Backianathan, Selvamani
    Chacko, Raju Titus
    CANCER INVESTIGATION, 2023, 41 (09) : 789 - 802